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cells expressing human OAT1
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Handling of cysteine S-conjugates of methylmercury in MDCK
cells expressing human OAT1.
Background. The activity of the organic anion transporter
1 (OAT1) has been implicated recently in the basolateral up-
take of thiol conjugates of inorganic mercury in renal proximal
tubular cells. However, very little is known about the role of
OAT1 in the renal epithelial transport of organic forms of mer-
cury, such as methylmercury (CH3Hg
+), especially when it is
in the form of the cysteine (Cys) S-conjugate of methylmercury
(CH3Hg-Cys), which is believed to be a biologically relevant
form of mercury.
Methods. Accordingly, the present study, was designed to
characterize the transport of CH3Hg-Cys in Madin-Darby ca-
nine kidney (MDCK) cells transfected stably with the human
isoform of OAT1 (hOAT1) and in proximal tubular–derived
NRK-52E cells.
Results. Data on saturation kinetics, time dependency, sub-
strate specificity, and temperature dependency demonstrate
that CH3Hg-Cys is transported by hOAT1. Substrate-specificity
data from the control cells also show that CH3Hg-Cys is a sub-
strate of one or more transporter(s) that is/are not hOAT1. Ad-
ditional findings indicate that at least one amino acid transport
system is involved in the uptake of CH3Hg-Cys in MDCK cells.
Furthermore, in the presence of cytotoxic concentrations of
CH3Hg-Cys, rates of survival were lower in hOAT1-transfected
cells than in wild-type control cells.
Conclusion. The present data demonstrate clearly that
CH3Hg-Cys is indeed a transportable substrate of OAT1. More-
over, the collective findings from the MDCK cells and NRK-52E
cells infer that CH3Hg-Cys is a likely transportable mercuric
species in proximal tubular epithelial cells that is taken up in
vivo by both OAT1 and amino acid transporters.
Methylmercury is the most prevalent species of mer-
cury found in the environment. It poses a potential health
risk to humans, especially to pregnant women and young
children, who consume contaminated fish or water. When
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humans and other mammals are exposed to organic forms
of mercury, mercuric ions gain access to a number of tar-
get compartments in the body, including the brain, liver,
and kidneys. Within the kidneys, mercuric ions primarily
gain entry into the epithelial cells lining proximal seg-
ments of the nephron, especially the pars recta of proxi-
mal tubules [1, 2]. As the burden of mercuric ions in these
target epithelial cells becomes too great for the cells to
handle, cellular intoxication and death occurs.
It is well established that mercuric ions have a predilec-
tion to bind to both protein and nonprotein thiols.
Moreover, there is evidence indicating that under cer-
tain conditions, the organometal complexes formed by
the coordinate covalent binding of an inorganic mer-
curic ion to the reduced sulfur atom of two molecules
of an endogenous nonprotein thiol, can behave chemi-
cally as a molecular “mimic” or functional homologue
of an essential biomolecule (such as an amino acid or
organic anion) [1–7]. In fact, recent cellular and molecu-
lar evidence from our laboratory indicates that molecular
“mimicry” is a mechanism involved in the luminal absorp-
tion of thiol S-conjugates of inorganic mercury by renal
epithelial cells. More specifically, we have shown that the
linear II, coordinate-covalent mercuric conjugate of cys-
teine (Cys), Cys-Hg-Cys, can serve as a molecular mimic
of the amino acid cystine (Cys-S-S-Cys) at the site of the
amino acid transporter system b0,+, which is an impor-
tant absorptive amino acid transporter found on the lumi-
nal plasma membrane of proximal tubular epithelial cells
[1, 8–11].
Interestingly, uptake of inorganic mercury by prox-
imal tubular epithelial cells is not restricted to trans-
port proteins located in the luminal plasma membrane.
Numerous lines of evidence indicate that mercuric ions
are also taken up (from the blood and extracellular fluid)
at the basolateral membrane by one or more organic
anion transport-system(s) [12–17]. Within the kidneys,
these transport systems are localized exclusively along
the proximal tubule, where they provide a secretory
mechanism for the elimination of many xenobiotics and
endogenous organic anions that escape filtration during
their passage through the kidney(s).
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One of the best characterized organic anion transport
(OAT) systems mediates the basolateral uptake of a wide
range of organic anions by a dicarboxylate/organic an-
ion exchanger. This transport protein has been denoted
as organic anion transporter 1 (OAT1), and is responsi-
ble for transporting a wide variety of organic anions into
the cytosolic compartment of proximal tubular epithelial
cells in exchange for molecules of a-ketoglutarate. The
intracellular-to-extracellular gradient of a-ketoglutarate
is maintained by both intracellular metabolism and
reclamation of a-ketoglutarate from the extracellular
compartment by the sodium-coupled dicarboxylate
transporter present in the basolateral membrane of prox-
imal tubular cells.
As alluded to above, OAT1 can mediate the uptake of
a host of low molecular weight and structurally dissimi-
lar organic acids and neutral compounds. Recent findings
from our laboratory provide the first lines of molecular
evidence indicating that Cys, homocysteine (Hcy), and
N-acetylcysteine (NAC) S-conjugates of inorganic mer-
cury can serve as transportable substrates of OAT1
[6, 7, 18].
Although there is considerable evidence from mam-
malian renal epithelial cells implicating thiol S-conjugates
of inorganic mercury as substrates of OAT1, little is
known about the potential role of this membrane trans-
porter in the basolateral uptake of thiol S-conjugates of
organic forms of mercury in the kidney. Inasmuch as
methylmercury (CH3Hg+) is the primary form of mer-
cury present in the environment, it is of paramount im-
portance to understand the mechanisms involved in the
transport and handling of this species of mercury in target
cells affected by this toxicant.
In the present study, we designed experiments to char-
acterize and compare the transport of Cys S-conjugates
of CH3Hg+ (CH3Hg-Cys) in Madin-Darby canine kid-
ney (MDCK) cells transfected stably with the human iso-
form of OAT1 (hOAT1). Inasmuch as MDCK cells are
derived from the distal nephron, direct molecular evi-
dence for the participation of OAT1 in the transport of
specific mercuric species could be obtained from a line of
mammalian renal epithelial cells that do not express or-
ganic anion transporters. The rationale for studying the
transport of Cys S-conjugates of methylmercury is that
this mercuric species has been implicated in the trans-
port of CH3Hg+ in endothelial cells and astrocytes of
the blood-brain barrier [3, 19]. We also studied the trans-
port of CH3Hg-Cys in NRK-52E cells, which are derived
from the renal proximal tubule of the rat. These cells
were chosen since they represent an established in vitro
model of proximal tubular epithelial cells in culture. Us-
ing the NRK-52E cells permitted us to assess similarities
in the mechanism in the luminal uptake of CH3Hg-Cys
between cells derived from the proximal tubule and dis-
tal regions of the nephron. Collectively, the findings from
the present study provide the first line of molecular ev-
idence from mammalian renal epithelial cells indicating
that CH3Hg-Cys can serve as a transportable substrate
of OAT1 and one or more amino acid transport systems.
METHODS
Transfection of MDCK-II cells with hOAT1
A subclone of Mycoplasma-free type II MDCK
cells was used in the present investigation. These cells
were originally developed in the laboratory of Dr. Kai
Simmons (EMBL, Heidelberg, Germany). As described
previously, [3, 18–20] these cells were transfected with
the cDNA for hOAT1 ligated to pcDNA3.1 (Invitro-
gen, Carlsbad, CA, USA) using Qiagen’s (Chatsworth,
CA, USA) SuperFect Reagent according to the manufac-
turer’s protocol (5 lL SuperFect/lg DNA). Subclones of
hOAT1-expressing (and wild-type) MDCK-II cells used
in the present investigation were provided as a gift by
Dr. John Pritchard at National Institute of Environmen-
tal Health Science (NIEHS). These subclones were main-
tained in culture media with 200 lg/mL geneticin (G418)
(Invitrogen), and were screened regularly for gaining
the ability to transport organic anions. This was accom-
plished by assaying uptake of [3H]-para-aminohippuric
acid (PAH) as described below.
Cell culture
When wild type and hOAT1-expressing MDCK cells
were grown in a confluent monolayer, the cell-to-cell at-
tachments afforded a low to moderate transepithelial
resistance. All MDCK-II cells were grown at 37◦C in
Eagle’s Minimum Essential Medium (EMEM) (Gibco
BRL, Rockville, MD, USA) supplemented with 1 mmol/L
sodium pyruvate and 10% fetal bovine serum (FBS)
(Gibco BRL). While in culture, the MDCK cells were
grown and maintained in a humidified atmosphere con-
sisting of 95% O2 and 5% CO2. Cells were split every 3 to
7 days, and 1/10th to 1/20th of the culture was inoculated
into new flasks.
NRK-52E cells were grown to confluency in Vitacell
Dulbecco’s modified Eagle’s medium (DMEM) (ATCC,
Manassas, VA, USA) supplemented with 4 mmol/L L-
glutamine, 4.5 g/L glucose, 1.5 g/L NaHCO3, and 10%
bovine calf serum (BCS). Cells were grown and main-
tained in a humidified atmosphere consisting of 95% O2
and 5% CO2. Cells were split every 5 to 7 days and were
subcultured into new flasks.
Uptake of PAH in hOAT1-transfected and
nontransfected MDCK-II cells
Dr. Pritchard’s laboratory had established that Inser-
tion of hOAT1 protein occurs at both apical and basolat-
eral plasma membranes in the MDCK cells transfected
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with the cDNA encoding hOAT1. Apical expression of
hOAT1 permits one to study hOAT1-dependent trans-
port using cells grown on a solid surface. Therefore,
uptake of [3H]-PAH (as well as other substrates) was as-
sessed in cells plated in 24-well (2.0 cm2 per well) cell-
culture cluster-plates (Costar Corning, New York, NY,
USA), containing supplemented EMEM, at a density of
0.5 × 106 cells per well (added as 2 mL). The cells were
grown to confluency in a humidified atmosphere of 95%
air and 5% CO2 for 2 days at 37◦C, with media being
changed after the first 24 hours.
Immediately prior to assessing transport parameters,
each well containing cells was first rinsed with Hank’s
buffered saline solution (HBSS) supplemented with 10
mmol/L 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic
acid (Hepes) (pH 7.4) for three consecutive 5-minute pe-
riods. At the beginning of each experiment, 350 lL of
the aforementioned HBSS containing 5.0 lmol/L PAH,
with or without 200 lmol/L probenecid, were added to
each well. Some of the PAH was in the form of [3H]-
PAH (4.54 mCi/lmol) (Perkin-Elmer Life and Analyti-
cal Sciences, Shelton, CT, USA). Following 60 minutes
of exposure to PAH, the cells in each well were rinsed
with cold (4◦C) “stop” buffer [HBSS supplemented with
10 mmol/L Hepes (pH 7.4)]. To determine the cellular
content of [3H]-PAH, cells were first lysed by adding 1
mL of 1 N NaOH to each well. The plates containing
NaOH were shaken overnight (for at least 12 hours) in
an orbital shaker operating at a rate of 500 rpm. Sub-
sequently, 700 lL of cellular lysate from each well were
neutralized with 700 lL of 1 N HCl. The total volume of
neutralized solution was added to 15 mL of Opti-Fluor
high-flash point liquid scintillation fluid (Perkin Elmer
Life and Analytical Sciences, Boston, MA, USA). The ra-
dioactivity in each sample was determined using a Beck-
man LS6000IC Liquid Scintillation Analyzer (Beckman
Instruments, Fullerton, CA, USA). Fifty microliters of
the remaining cellular lysate from each well were used
to determine the total amount of protein per well using
the Bradford protein assay [21]. Transport data obtained
from each well of cells were normalized to the corre-
sponding concentration of cellular protein and rates of
cellular uptake of [3H]-PAH were expressed as pmol ×
mg protein−1 × min−1.
Experimental design
Concentration-dependence, time-dependence, tem-
perature-dependence, and substrate specificity for the
extracellular to intracellular transport of CH3Hg-Cys
were characterized and compared in both hOAT1-
transfectants and corresponding wild-type control
MDCK cells. The hOAT1 component for the uptake of
CH3Hg+ (in the form of CH3Hg-Cys) from the hOAT1-
transfected cells and the concentration dependent data
from the control cells were fitted to the Michaelis-Menten
equation. In addition, linear regression analysis was ap-
plied to transport data plotted by the Eadie-Hofstee
method, where velocity (V) is plotted against the quo-
tient of velocity divided by the concentration of substrate
(V/[S]). The slope of each regression line determined by
this method is equal to the negative of the Michaelis-
Menton constant (−Km). By using these equations; we
were able to characterize the kinetics of the transport of
CH3Hg-Cys.
Transport of CH3Hg+ in hOAT1-transfected and
nontransfected MDCK-II cells and NRK-52E cells
In the experiments where the transport of Cys S-
conjugates of CH3Hg+ were studied, both the MDCK
cells and NRK-52E cells (which are derived from
the rat proximal tubule) were also plated in 24-well
(2.0 cm2) cell-culture-cluster-plates (Costar Corning),
containing supplemented DMEM, at a density of 0.5 ×
106 cells/well (added as 2 mL). They were then grown in
a humidified atmosphere of 95% air and 5% CO2 for 3
days at 37◦C with media being changed after the first 24
hours. During the assessment of transport activity, me-
dia were aspirated from the wells and cells were rinsed
three times with 3 mL of HBSS supplemented with 10
mmol/L Hepes (pH 7.4). Three hundred and fifty micro-
liters of transport buffer (specific to each experiment)
containing radioactive methylmercury ([14C]-CH3Hg+)
(20 mCi/mmol) (American Radiolabeled Chemical Inc.,
St. Louis, MO, USA) were added to each well.
In selective experiments, competitive inhibitors of
OAT1, such as PAH or the dicarboxylates, adipate or
glutarate, were added to the transport buffer. In addi-
tional experiments, the influence of various L-type amino
acids (such as leucine, isoleucine, methionine, alanine,
and phenylalanine) on the transport of CH3Hg-Cys was
assessed.
L-Cys was added in a 2:1 mol ratio with CH3Hg+ to en-
sure that each methyl mercuric ion in solution formed a
thermodynamically stable, linear-I, coordinate-covalent
complex with a molecule of Cys. The association con-
stant for the bonding of mercuric ions to the sulfur atom
of low-molecular-weight thiols is more than ten orders
of magnitude greater than that for the bonding of mer-
curic ions to any other biologically occurring nucleophilic
group [1].
At the end of a particular exposure, the cells in each
well were rinsed with cold (4◦C) “stop” buffer [HBSS
supplemented with 10 mmol/L Hepes (pH 7.4) con-
taining 1 mmol/L 2,3-dimercaptopropane-1-sulfonic acid
(DMPS), and 200 lmol/L probenecid]. DMPS is a very
effective dithiol chelator of mercuric ions. It was used to
reduce the pool of mercuric ions bound to outer surfaces
of the plasma membrane to negligible levels. Since DMPS
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oxidizes rapidly in aqueous solutions, it was mixed into
solution within the first 15 minutes of its use. Probenecid
was used in the stop buffer, at the termination of each
experiment, as an added measure to inhibit the activity
of OAT1.
Cellular content of [14C]-labeled CH3Hg+ was deter-
mined by liquid scintillation spectrometry after adding 1
mL of 1 N NaOH to each well. After adding the NaOH,
the 24-well plates were shaken in an orbital shaker at 500
rpm for at least 12 hours. Seven-hundred microliters of
cellular lysate from each well were neutralized with 700
lL of 1 N HCl. The total volume of neutralized solution
was added to 15 mL of Opti-Fluor (Perkin Elmer Life
and Analytical Sciences) scintillation fluid. The radioac-
tivity of each sample was determined using a Beckman
LS6000IC Liquid Scintillation Analyzer) (203Hg counting
efficiency ∼ 80% to 90%). Fifty microliters of the remain-
ing cellular lysate from each well were used to determine
the total amount of protein per well by the Bradford pro-
tein assay. Transport data obtained from each well of cells
were normalized to the corresponding concentration of
cellular protein.
Assessment of toxicity and cellular viability
The effects of the mercuric conjugates CH3Hg-Cys on
cellular viability were measured using a methylthiazolete-
trazolium (MTT)-based toxicity assay (Sigma Chemical
Co., St. Louis, MO, USA). This assay measures the activ-
ity of mitochondrial dehydrogenase by the conversion of
the yellow tetrazolium dye MTT to purple formazan crys-
tals. Cells were plated in supplemented EMEM at a den-
sity of 5.0 × 104 cells/well (added as 200 lL/well) in sterile
96-well microtiter plates (Costar Corning) and allowed to
grow for 48 hours in a humidified atmosphere of 5% CO2,
95% air at 37◦C. Supplemented EMEM was changed af-
ter the first 24 hours by inversion. Excess media adhering
to the plate was blotted off with sterile gauze (Johnson
& Johnson, Arlington, TX, USA). After 48 hours, wells
were again washed three times with 200 lL of HBSS per
well. After washing, test compounds were added to in-
dividual wells (200 lL/well) in unsupplemented EMEM,
and cells were grown for 6 hours in a humidified atmo-
sphere of 5% CO2, 95% O2 at 37◦C. At the conclusion of
the exposure period, media were removed by inversion
and blotting, wells were washed with 200 lL HBSS, and
100 lL of 0.5 mg/mL (1.2 mmol/L) MTT in HBSS was
added to each well. Cells were incubated for 2 hours and
100 lL of solubilization buffer (10% Triton X-100 and 0.1
N HCl in isopropyl alcohol) were added to each well. This
buffer both lysed the cells (releasing the formazan) and
dissolved the water-insoluble formazan crystals. After an
overnight incubation at room temperature, full solubi-
lization had occurred, and plates were read at 595 nm in
a Titertek Multiskan MKII plate reader (Fisher Scientific,
Suwanee, GA, USA).
Statistical analysis
Results are presented as representative data from at
least two sets of experiments. Data are expressed as the
mean ± standard error. For uptake studies a sample size
of N = 3 or 4 was used. Assuming that each sample was
mutually independent, statistical analysis for each param-
eter assessed in the MDCK cells was performed by first
using a two-way analysis of variance (ANOVA), followed
by either Tukey’s or Dunnett’s post hoc test. The data ob-
tained from the NRK-52E cells were analyzed by using a
one-way ANOVA, followed by the Tukey’s multiple com-
parison, post hoc test. Data expressed as a percent were
first normalized using the arcsine transformation prior to
applying parametric statistical analyses. This transforma-
tion takes the arcsine of the square root of the decimal
fraction of the percent score. Differences among means
were considered statistically significant at P < 0.05.
RESULTS
Uptake of PAH
Insertion of a functional hOAT1 transporter into
the plasma membranes of the MDCK-II cells trans-
fected with hOAT1 was confirmed by assessing uptake
of [3H]-PAH (a high-affinity substrate of this organic
anion/dicarboxylate exchanger). At an extracellular
concentration of 5 lmol/L, PAH was taken up from the
extracellular environment into the cytosolic compart-
ment by the hOAT1-transfected MDCK cells at a rate
of 9.4 ± 0.7 pmol × mg protein−1 × min−1. Addition of
200 lmol/L probenecid to the extracellular media caused
the rate of uptake of PAH in the transfected cells to
decrease to an average level 0.8 ± 0.1 pmol × mg pro-
tein−1 × min−1. By contrast, uptake of PAH in the wild-
type MDCK cells was insignificant, averaging only about
0.10 ± 0.01 pmol × mg protein−1 × min−1. Probenecid
did not have a significant effect on the uptake of PAH
in the wild-type control cells (0.10 ± 0.01 pmol × mg
protein−1 × min−1).
Based on these gain-of-function findings, it is clear that
a functional form of hOAT1 was indeed being inserted
into the plasma membranes of the hOAT1-transfected
MDCK cells.
Concentration-dependent uptake of CH3Hg+
Assessment of the concentration dependence and sat-
uration kinetics for the uptake of CH3Hg+ revealed that
the uptake of this species of mercury, when presented
as CH3Hg-S-Cys, was greater in hOAT1-transfected
MDCK-II cells than in corresponding control cells
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Fig. 1. Concentration-dependent uptake (pmol × mg cellular protein−1 × min−1) of methylmercury (CH3Hg+) in control and human organic
anion transporter-1 (hOAT1)-expressing Madin-Darby canine kidney (MDCK)-II cells exposed to cysteine (Cys) CH3Hg (CH3Hg-Cys). Cellular
uptake was studied for 30 minutes (at 37◦C). Inset, Eadie-Hofstee plot of the uptake of CH3Hg+ in the control MDCK-II cells exposed to CH3Hg-
Cys. Each value represents the mean ± SE for a sample size of three or four. ∗Significantly different (P < 0.05) from the mean for the corresponding
group of control MDCK cells.
(Fig. 1). Interestingly, the kinetic data indicate that car-
rier mediated processes were involved in the uptake of
CH3Hg+ in both the hOAT1-transfected and wild-type
control MDCK-II cells, although the levels of uptake
were overall greater in the hOAT1-transfected cells.
Analysis of kinetic parameters revealed that the appar-
ent Km for the uptake of CH3Hg+ in the control MDCK
cells was 42 ± 10 lmol/L, while the Vmax was 127 ± 9
pmol × mg protein−1 × min−1 (Fig. 1). In the hOAT1-
transfected MDCK cells, the apparent Km for the uptake
of CH3Hg+ that could be attributed to hOAT1 (hOAT1
minus control) was 36 lmol/L and the Vmax was 50 pmol
× mg protein−1 × min−1 (Fig. 2).
Time-dependent uptake of CH3Hg+
Time-dependent uptake of CH3Hg+, when presented
as 5 lmol/L CH3Hg-Cys, was detected in both the
hOAT1-transfected and wild-type control MDCK cells
(Fig. 3). However, the rates of uptake of CH3Hg+ were
significantly greater in the MDCK cells transfected with
the cDNA for hOAT1 than in the corresponding control
MDCK cells at almost all of the times studied. The great-
est differences in the transport of CH3Hg+ between the
hOAT1-transfected and wild-type control cells were de-
tected at 60 and 120 minutes of exposure.
Effect of PAH and probenecid on the uptake of
CH3Hg+
Addition of 1 mmol/L PAH or 200 lmol/L probenecid
to the extracellular compartment containing 5 lmol/L
CH3Hg-Cys did not affect significantly the uptake of
CH3Hg+ in the control MDCK cells during 60 minutes
of exposure (Fig. 4). By contrast, addition of PAH or
probenecid to the extracellular medium caused the up-
take of CH3Hg+ to decrease significantly in the hOAT1-
transfected MDCK cells (Fig. 4).
Effect of dicarboxylates on the uptake of CH3Hg+
Uptake of CH3Hg+ was unaffected in the control
MDCK cells when 1 mmol/L glutarate or adipate was
added to the extracellular medium containing 5 lmol/L
CH3Hg-Cys during 60 minutes of exposure (Fig. 5). How-
ever, both of these dicarboxylates did cause the uptake
of CH3Hg+ to be decreased significantly in the hOAT1-
transfected MDCK cells (Fig. 5).
Effect of temperature on the uptake of CH3Hg+
Significant temperature-dependent differences in the
extracellular to intracellular transport of CH3Hg+ were
detected among the groups of corresponding hOAT1-
transfected and wild-type control cells.
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At 37◦C, uptake of CH3Hg+ was significantly greater
in the hOAT1-transfected MDCK cells than in the cor-
responding wild-type control MDCK cells when the cells
were exposed to 5 lmol/L CH3Hg-Cys during 1 hour of
exposure (Fig. 6).
When the extracellular temperature was reduced to
21◦C, uptake of CH3Hg+ in the hOAT1-transfected and
wild-type control MDCK cells was significantly lower
than that detected at 37◦C (Fig. 6). In addition, there
was no significant difference in the rate of uptake of
CH3Hg+ between the two corresponding groups of
hOAT1-expressing cells and wild-type control cells.
Transport of CH3Hg+ was for the most part abolished
in both the hOAT1-expressing cells and the wild-type
control cells when the temperature of the extracellular
medium was reduced to 4◦C. The level of CH3Hg+ de-
tected in both cell types at this temperature likely repre-
sents nonspecific binding.
Assessment of toxicity and cellular viability
During 6 hours of exposure to CH3Hg-Cys, signif-
icant decreases in the cellular viability were detected
(Fig. 7). Greater decreases in survival were detected in
the hOAT1-expressing cells than in the corresponding
control cells at each concentration of CH3Hg-Cys stud-
ied (Fig. 7).
Effect of L-amino acids on the uptake of CH3Hg+
Uptake of CH3Hg+ was significantly greater in the
hOAT1-transfected MDCK cells exposed to 5 lmol/L
CH3-Hg-Cys than in the corresponding wild-type con-
trol MDCK cells (Fig. 8). Addition of 1 mmol/L vari-
ous L-isomers of amino acids to the extracellular medium
induced significant effects on the transport of CH3Hg+
in both control and hOAT1-transfected MDCK cells.
Among the control MDCK cells exposed to CH3Hg-Cys,
significant effects on the uptake of CH3Hg+ were de-
tected in all groups exposed to an amino acid except for
the group of cells exposed to 1 mmol/L L-methionine.
Among the hOAT1-expressing cells exposed to amino
acids, the levels of uptake of CH3Hg+ were reduced sig-
nificantly in all groups of cells exposed to an amino acid.
In both the control and hOAT1-expressing cells, addi-
tion of 1 mmol/L L-cysteine to the extracellular compart-
ment had the greatest effect on the uptake of CH3Hg+.
Addition of 1 mmol/L L-leucine had the second greatest
effect on the uptake of CH3Hg+, but only in the control
cells.
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the mean ± SE for a sample size of three or four. ∗Significantly different (P < 0.05) from the mean for the corresponding group of control MDCK
cells.
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Fig. 4. Influence of 200 lmol/L probenecid or 1 mmol/L [3H]-paraaminohippuric acid (PAH) on the uptake (pmol × mg cellular protein−1 ×
min−1) of methylmercury (CH3Hg+) in control and human organic anion transporter-1 (hOAT1) expressing Madin-Darby canine kidney (MDCK)-
II cells exposed to 5 lmol/L cysteine CH3Hg (CH3Hg-Cys) for 60 minutes (at 37◦C). Each value represents the mean ± SE for a sample size of three
or four. ∗Significantly different (P < 0.05) from the mean for the corresponding group of wild-type control MDCK cells; +Significantly different
(P < 0.05) from the mean for the corresponding group of hOAT1 expressing MDCK cells not exposed to either PAH or probenecid.
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corresponding group of hOAT1 expressing MDCK cells not exposed to either dicarboxylic acid.
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Fig. 6. Effect of temperature on the up-
take (pmol × mg cellular protein−1 ×
min−1) of methylmercury (CH3Hg+) in con-
trol and human organic anion transporter-
1 (hOAT1) expressing Madin-Darby canine
kidney (MDCK)-II cells exposed to 5 lmol/L
cysteine (Cys) CH3Hg (CH3Hg-Cys) for 60
minutes. Each value represents the mean
± SE for a sample size of three or four.
∗Significantly different (P < 0.05) from the
mean for the corresponding group of wild-
type control MDCK cells treated in the same
manner; +Significantly different (P < 0.05)
from the mean for the corresponding group of
MDCK cells treated at 37◦C; ++Significantly
different (P < 0.05) from the mean for the
corresponding group of MDCK cells treated
at 37◦C or 21◦C.
Effect of L-leucine and/or PAH on the uptake
of CH3Hg+
Significant differences in the uptake of CH3Hg+
were again detected between the control and hOAT1-
expressing MDCK cells exposed to 5 lmol/L CH3Hg-
Cys (Fig. 9). Among the control and hOAT1-expressing
MDCK cells, uptake of CH3Hg+ in the group exposed
to 1 mmol/L L-leucine was significantly lower than that
in the corresponding group treated with only 5 lmol/L
CH3Hg-Cys during 30 minutes of exposure.
Addition of 1 mmol/L PAH to the extracellular com-
partment did not have a significant effect on the up-
take of CH3Hg+ in the control MDCK cells, but did
have a significant effect on the uptake of CH3Hg+ in the
hOAT1-expressing cells (Fig. 9). In fact, the effect of PAH
was just as great as L-leucine in the hOAT1-expressing
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Fig. 8. Influence of extracellular amino acids (1 mmol/L) on the uptake (pmol × mg cellular protein−1 × min−1) of methylmercury (CH3Hg+)
in control and human organic anion transporter-1 (hOAT1) expressing Madin-Darby canine kidney (MDCK)-II cells exposed to 5 lmol/L cysteine
(Cys) CH3Hg (CH3Hg-Cys) for 60 minutes (at 37◦C). All amino acids used were L isomers. Each value represents the mean ± SE for a sample size
of three or four. ∗Significantly different (P < 0.05) from the mean for the corresponding group of wild-type control MDCK cells treated in the same
manner; +Significantly different (P < 0.05) from the mean for the corresponding group of control or hOAT1 expressing MDCK cells exposed to 5
lmol/L CH3Hg-Cys without any additional amino acids added.
cells, inasmuch as no significant difference in the up-
take of CH3Hg+ was detected between the group of cells
treated with L-leucine and the group of cells exposed to
PAH.
When both PAH and L-leucine were added to the
extracellular medium, an additive inhibitory effect on
the uptake of CH3Hg+ was detected only among the
groups of hOAT1-expressing MDCK cells (Fig. 9). No
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Fig. 9. Effect of adding 1 mmol/L L-leucine and/or 1 mmol/L [3H]-paraaminohippuric acid (PAH) on the uptake (pmol × mg cellular protein−1 ×
min−1) of methylmercury (CH3Hg+) in control and human organic anion transporter-1 (hOAT1) expressing Madin-Darby canine kidney (MDCK)-
II cells exposed to 5 lmol/L cysteine (Cys) CH3Hg (CH3Hg-Cys) for 30 minutes (at 37◦C). Each value represents the mean ± SE for a sample
size of three or four. ∗Significantly different (P < 0.05) from the mean for the corresponding group of wild-type control MDCK cells treated in the
same manner; +Significantly different (P < 0.05) from the mean for the corresponding group of control or hOAT1 expressing MDCK cells exposed
to 5 lmol/L CH3Hg-Cys without any additional amino acids added; ++Significantly different (P < 0.05) from the means for all of corresponding
groups of control or hOAT1 expressing MDCK cells.
significant difference in the uptake of CH3Hg+ was de-
tected between the group of control MDCK cells exposed
to 5 lmol/L CH3Hg-Cys and 1 mmol/L L-leucine and the
corresponding group of control MDCK cells exposed to
5 lmol/L CH3Hg-Cys, 1 mmol/L L-leucine, and 1 mmol/L
PAH.
Effect of L-amino acids on the uptake of CH3Hg+
in NRK-52E cells
In the absence of 140 mmol/L extracellular Na+, uptake
of CH3Hg+ during 15 minutes of exposure, was signifi-
cantly lower in all of the groups exposed to both 5 lmol/L
CH3Hg-Cys and 1 mmol/L of one of the amino acids stud-
ied than in the control group of cells exposed to only 5
lmol/L CH3Hg-Cys (Fig. 10A). Addition of 1 mmol/L
cysteine had the greatest inhibitory effect on the uptake
of CH3Hg+. The next greatest level of inhibition in the
uptake of CH3Hg+ was detected in the groups of cells
exposed to L-leucine, L-isoleucine, or L-phenylalanine.
In the presence of 140 mmol/L extracellular Na+, a sim-
ilar pattern for uptake of CH3Hg+ was detected among
the same groups of cells studied under Na+-dependent
conditions during 15 minutes of exposure (Fig. 10B).
However, the overall levels of uptake tended to be lower
under Na+-independent conditions, indicating that much
of the transport detected was mediated primarily by one
or more Na+-independent transporters.
Effect of PAH, probenecid, and glutarate on the uptake
of CH3Hg+in NRK-52E cells
Uptake of CH3Hg+ by NRK-52E cells exposed to
5 lmol/L CH3Hg-Cys for 15 minutes (in the presence
of 140 mmol/L Na+) was unaffected by the addition of
1 mmol/L PAH, 0.2 mmol/L probenecid, or 1 mmol/L
glutarate to the extracellular compartment.
DISCUSSION
Due to the continuing risk of humans being exposed
to various forms of mercury [1], there is a growing need
to better understand how the various chemical species
of this metal are handled by humans and other species
of mammals. In order for one to comprehend how these
mercuric species induce their deleterious effects in a par-
ticular organism, it is paramount for one to understand
how mercuric ions (in their varied forms) gain entry into
the target cells they affect.
Over the past decade, a number of studies have been
carried out in an attempt to characterize the disposition
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Fig. 10. Uptake of methylmercury (CH3Hg
+) (pmol × mg cellular protein−1 × min−1) in NRK-52E cells exposed to 5 lmol/L cycsteine (Cys)
CH3Hg (CH3Hg-Cys) for 15 minutes (at 37◦C) in the absence and presence of 1 mmol/L leucine, isoleucine, phenylalanine, cysteine, lysine,
glutamate, or methionine and in the presence (A) or absence (B) of 140 mmol/L extracellular Na+. All amino acids used were L isomers. Each value
represents the mean ± SE for a sample size of three or four. +Significantly different (P < 0.05) from the mean for the corresponding group of control
NRK-52E cells exposed to 5 lmol/L CH3Hg-Cys; ++Significantly different (P < 0.05) from the preceding means for all of corresponding groups
of NRK-52E cells exposed to 5 lmol/L CH3Hg-Cys with or without 1 mmol/L leucine, isoleucine, or phenylalanine; +++Significantly different
(P < 0.05) from all of the other corresponding groups of NRK-52E cells.
and transport of inorganic and organic forms of mercury
in target organs [1]. The findings from a number of these
studies have established that the kidneys are the primary
sites in the body where Hg2+ and CH3Hg+ are taken
up and accumulated, and that the preponderance of this
accumulation is linked to uptake of thiol S-conjugates of
these mercuric species by proximal tubular epithelial cells
[1, 22–24]. More important, these findings indicate that
at least one luminal mechanism and at least one basolat-
eral mechanism are involved in the uptake of mercury by
proximal tubular epithelial cells [12–17, 25–29].
With the discovery that Hg2+ is taken up at the basolat-
eral membrane of proximal tubular epithelial cells in vivo,
it was determined that much of this uptake could be in-
hibited by the systemic administration of PAH [12, 13, 15,
16, 29]. Since PAH is a high-affinity substrate of the dicar-
boxylate/organic anion exchanger OAT1, it seemed log-
ical for us to postulate that organic anion transporter(s)
is/are involved in the basolateral uptake of Hg2+ [12–17,
25, 28–30]. However, prior to the present study, very little
was known about the potential role of OAT1 in the renal
tubular uptake of CH3Hg+ [1], especially in the form of
thiol S-conjugates.
Thus, in the present study, we tested directly the hy-
pothesis that the Cys S-conjugate of CH3Hg+ is a trans-
portable substrate of the membrane transport protein,
OAT1 (specifically hOAT1). We tested this hypothesis by
characterizing and comparing the transport of CH3Hg-
Cys in a line of MDCK-II cells transfected stably with
the cDNA encoding the human isoform of the renal
dicarboxylate/organic anion exchanger 1 (hOAT1).
We first established that expression and membrane-
insertion of a fully functional hOAT1 protein was
occurring in the transfected MDCK-II cells. This was
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Fig. 10. (Continued.)
accomplished by demonstrating concentration- and time-
dependent transport of PAH in only the hOAT1-
transfected cells, and by confirming the inhibitory effects
of probenecid or small dicarboxylates on the uptake of
PAH [6, 7, 15–17, 28]. Only then did we begin to character-
ize the transport of CH3Hg+ in the form of CH3Hg-Cys.
Analysis of saturation kinetics and time-dependency
for the transport of CH3Hg-Cys in both the hOAT1-
transfected and wild-type MDCK cells demonstrate
clearly that CH3Hg-Cys is taken up to a greater extent
in MDCK cells expressing hOAT1 than in correspond-
ing control MDCK cells. Moreover, both analysis of the
saturations kinetics and assessment of temperature de-
pendency of the transport of CH3Hg-Cys indicate that
the enhanced uptake of CH3Hg-Cys in the hOAT1 ex-
pressing cells is due to a carrier-mediated process (i.e.,
the activity of the hOAT1 transport protein).
In proximal tubular segments in vivo, the downhill,
intracellular-to-extracellular chemical gradient for a-
ketoglutarate serves to facilitate the transport of organic
anions into the cytosolic compartment by a molecular
exchange mechanism mediated by OAT1. Other dicar-
boxylates, such as adipate and glutarate, also compete
for OAT1 [6, 7, 15–17, 28]. In the present study, we
demonstrate that the uptake of CH3Hg-Cys in MDCK
cells expressing hOAT1 is not only inhibited by PAH and
probenecid, but by adipate or glutarate (Figs. 4 and 5).
These findings, therefore, serve as additional evidence im-
plicating Cys S-conjugates of CH3Hg+ as transportable
substrates of hOAT1.
OAT1 ostensibly has the ability to transport a broad
spectrum of functionally and/or structurally similar
molecules. This transport is greatly dependent on molecu-
lar structure-function relationships that exist between the
transporter and substrate. Molecular homology among
substrates appears to play an important role in the activ-
ity of OAT1. In support of this hypothesis are recent data
implicating OAT1 in the transport of inorganic mercuric
conjugates of NAC (NAC-S-Hg-S-NAC), Cys (Cys-S-Hg-
S-Cys), and Hcy (Hcy-S-Hg-S-Hcy) [6, 7, 15–17, 28].
In contrast to the present findings, Koh et al [31] pro-
vide data showing that uptake of CH3Hg-Cys in Xenopus
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Fig. 11. Apical (luminal) uptake of methylmercury (CH3Hg
+) (pmol × mg cellular protein−1 × min−1) in NRK-52E cells exposed to 5 lmol/L
cysteine (Cys) CH3Hg (CH3Hg-Cys) or 15 minutes (at 37◦C) in the presence and absence of 1.0 mmol/L [3H]-paraaminohippuric acid (PAH),
0.2 mmol/L probenecid, or 1 mmol/L glutarate. Each value represents the mean ± SE for a sample size of three or four. Mean values were not
statistically different from one another.
(laevis) oocytes expressing rat OAT1 or OAT3 was not
significantly different from that in corresponding control
oocytes. It is not clear why rOAT1-dependent uptake of
CH3Hg-Cys was not detected in the oocytes studied by
Koh et al, although species-variants in OAT1 may have
played a role. It should also be pointed out that among the
control groups of oocytes, uptake of CH3Hg-Cys was at
least threefold greater than the uptake of methylmercuric
conjugates of NAC, glutathione, cysteinylglycine, peni-
cillamine, DMPS, or dimercaptosuccinic acid (DMSA).
Thus, an inherent mechanism in the control oocytes ap-
pears to have been responsible for a significant level of
uptake of CH3Hg-Cys. This inherent mechanism of up-
take could have overshadowed or diluted the activity of
rOAT1 or rOAT3.
OAT3 is an additional organic transporter localized
in the basolateral plasma membrane of proximal tubu-
lar epithelial cells in vivo. Some of the same substrates
transported by OAT1 also appear to be taken up by
OAT3. For example, we recently obtained unpublished
findings showing that the inorganic mercuric conjugate
Cys-Hg-Cys is not only a substrate in hOAT1-transfected
MDCK cells and hOAT1-expressing X. laevis oocytes [7],
but is also a transportable substrate in Xenopus oocytes
expressing rOAT3. However, further experiments are
needed to determine if OAT3 participates in the trans-
port of CH3Hg-Cys in mammalian cells expressing this
protein.
Interestingly, two distinct carrier-mediated mecha-
nisms for the uptake of CH3Hg-Cys were implicated
between the two populations of MDCK cells studied.
The first mechanism was the PAH- and dicarboxylate-
sensitive component afforded exclusively to the hOAT1-
transfected MDCK cells. Unexpectedly, though, a sig-
nificant level of uptake of CH3Hg-Cys also occurred in
the wild-type control MDCK cells. However, this up-
take was not linked to a mechanism sensitive to PAH,
probenecid, adipate, or glutarate, but was found to be
concentration, time, and temperature dependent and was
substrate specific. Clearly, a disparate mechanism, not
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Fig. 12. Diagrammatic representation of the role of organic anion transporter-1 (OAT1) and amino acid transporters in the basolateral uptake of the
cysteine (Cys) S-conjugate of methylmercury (CH3Hg
+), CH3Hg-Cys, in a proximal tubular epithelial cell. In this representation, the intracellular
concentration of a-ketoglutarate and the extracellular concentration CH3Hg-Cys provide the energy to allow a-ketoglutarate to be transported
out of the proximal tubular epithelial cell in exchange for CH3Hg-Cys by OAT1. This diagram also illustrates that amino acid transport proteins
likely participate in the luminal and/or basolateral uptake of CH3Hg-Cys. The three-dimensional, space-filled, molecular model was generated in
part with MOLPOV2 and persistence of vision (POV), version 3.5.
involving hOAT1, was involved in this transport. The data
obtained from the study of the effects of amino acids
on the transport of CH3Hg-Cys show that this mech-
anism is likely mediated by one or more amino acid
transporters native to the MDCK cells. In both types
of MDCK cells, exposure to 1 mmol/L L-Cys, L-leucine,
L-isoleucine, L-phenylalanine, L-threonine, L-alanine, or
L-glutamate had the greatest inhibitory effects on the up-
take of CH3Hg-Cys. Of note, however, is the fact that
L-methionine did not have a significant effect on the up-
take of CH3Hg-Cys in the control MDCK cells. Among
the MDCK cells expressing hOAT1, methionine did have
a significant effect on the uptake of CH3Hg-Cys, al-
though it was the least effective in inhibiting the uptake
of CH3Hg-Cys.
Additional evidence for a second mechanism being
involved in the uptake of CH3Hg-Cys in the hOAT1-
expressing cells was revealed by the additive effects that
PAH and L-leucine (Fig. 9). The findings from these ex-
periments indicate that the overall transport of CH3Hg-
Cys in the hOAT1-transfected cells was mediated by both
hOAT1 and one or more amino acid transporters.
For the sake of comparison, we also studied the api-
cal (luminal) uptake of CH3Hg-Cys in NRK-52E cells,
which are derived from the proximal tubule of the rat.
Assessment of the effects of amino acids on the up-
take of CH3Hg-Cys revealed that the apical uptake
of CH3Hg-Cys in the NRK-52E cells was due primar-
ily to one or more Na+-independent amino acid trans-
porters. Although L-cysteine, L-leucine, L-isoleucine, and
L-phenylalanine were most effective in inhibiting the up-
take of CH3Hg-Cys, L-methionine also had a significant
inhibitory effect. Apical uptake of CH3Hg-Cys was con-
firmed by the data obtained with PAH, probenecid, and
glutarate. These substrates did not affect the uptake of
CH3Hg-Cys when it was presented to the apical plasma
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membrane. This lack of effect is consistent with the fact
that OAT1 is located predominantly on the basolateral
membrane, which was apparently not accessible to a sig-
nificant degree in the monolayer cultures of NRK-52E
cells.
It is noteworthy to mention that molecular mimicry
has been suggested to be involved in the uptake of Cys
S-conjugates of CH3Hg+ in glial and endothelial cells [3,
19, 32]. CH3Hg-S-Cys has been hypothesized to serve as
a molecular mimic of the amino acid methionine at one or
more neutral amino acid transporters (Clarkson, 1993).
Recent data obtained from Xenopus oocytes expressing
the neutral amino acid transporters LAT1 or LAT2 pro-
vide evidence supporting this hypothesis [4].
Although this form of molecular mimicry is supported
in part by findings obtained from the NRK-52E cells, the
findings obtained from the MDCK cells in the present
study do not. Unfortunately, the present data do not pro-
vide sufficient evidence for one to identify the specific
amino acid transporter(s) involved in the uptake CH3Hg-
Cys in either the MDCK cells or NRK-52E cells.
Decreased survival of hOAT1-expressing and control
MDCK cells occurred following exposure to various toxic
concentrations of CH3Hg-Cys. However, the percentage
of cells surviving 6 hours of exposure was significantly
greater in the wild-type control cells than in the hOAT1-
expressing cells. This pattern of increased severity of cel-
lular injury in the hOAT1-expressing cells correlates with
the fact that an additional mechanism (i.e., the activ-
ity hOAT1) contributed to the over level of uptake of
CH3Hg-Cys.
CONCLUSION
The findings from the present study represent the first
line of direct molecular evidence from hOAT1-expressing
renal epithelial cells implicating the basolateral organic
anion/dicarboxylate transporter OAT1 in the renal ep-
ithelial uptake of, and intoxication with, Cys S-conjugates
of CH3Hg+. These data support the hypothesis that one
of the mechanisms by which proximal tubule take up
CH3Hg+ involves the basolateral uptake of CH3Hg-
Cys via OAT1. Moreover, the present findings also in-
dicate that the mercuric conjugate CH3Hg-Cys can be
transported by Na+-independent amino acid transporters
present in the plasma membranes of epithelial cells lin-
ing both proximal and distal segments of the nephron.
Figure 12 presents a diagrammatic representation of the
putative roles of OAT1 and amino acids transporters
in the proximal tubular uptake of CH3Hg+ as the Cys
S-conjugate, CH3Hg-Cys.
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